The Global Medical Cannabis Market is estimated to be USD 9.61 Bn in 2022 and is expected to reach USD 24.86 Bn by 2027, growing at a CAGR of 20.94%.
Market Dynamics
Market dynamics are forces that impact the prices and behaviors of the Global Medical Cannabis Market stakeholders. These forces create pricing signals which result from the changes in the supply and demand curves for a given product or service. Forces of Market Dynamics may be related to macro-economic and micro-economic factors.
There are dynamic market forces other than price, demand, and supply. Human emotions can also drive decisions, influence the market, and create price signals. As the market dynamics impact the supply and demand curves, decision-makers aim to determine the best way to use various financial tools to stem various strategies for speeding the growth and reducing the risks.
Company Profiles
The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for the publicly listed companies in the market. The report also offers detailed information on the companies' recent development and competitive scenario. Some of the companies covered in this report are Cannabis Sativa, Inc., Cara Therapeutics Inc., Growblox Sciences, Inc., Jazz Pharmaceuticals plc, VIVO Cannabis Inc., etc.
Countries Studied
America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)
Competitive Quadrant
The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.
Ansoff Analysis
The report presents a detailed Ansoff matrix analysis for the Global Medical Cannabis Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.
The analyst analyses the Global Medical Cannabis Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position. Based on the SWOT analysis conducted on the industry and industry players, the analyst has devised suitable strategies for market growth.
Why buy this report?
The report offers a comprehensive evaluation of the Global Medical Cannabis Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
The report includes an in-depth market analysis using Porter's 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
The report also contains the competitive analysis using Positioning Quadrants, the analyst's Proprietary competitive positioning tool.
Key Topics Covered:
1 Report Description
2 Research Methodology
3 Executive Summary
4 Market Dynamics 4.1 Drivers 4.1.1 Increasing Demand for Medical Cannabis Chronic Compounds 4.1.2 Increasing Population and Rise in the Prevalence of Chronic Diseases 4.1.3 Raising Awareness About Benefits of Medical Marijuana 4.2 Restraints 4.2.1 High Pricing of Medical Cannabis 4.3 Opportunities 4.3.1 Emergence of Cannabis Legalization 4.4 Challenges 4.4.1 Intensive Energy Consumption and Maintaining Product Consistency for the Cultivation of Cannabis
5 Market Analysis 5.1 Regulatory Scenario 5.2 Porter's Five Forces Analysis 5.3 Impact of COVID-19 5.4 Ansoff Matrix Analysis
6 Global Medical Cannabis Market, By Product Type 6.1 Introduction 6.2 Concentrates 6.3 Flower 6.4 Leaves 6.5 Seeds
7 Global Medical Cannabis Market, By Applications 7.1 Introduction 7.2 Chronic Pain 7.3 Mental Disorders 7.4 Cancer 7.5 Others
8 Global Medical Cannabis Market, By Form 8.1 Introduction 8.2 Concentrated Oil 8.3 Cream 8.4 Inhaled Liquids 8.3 Supplement Capsule 8.4 Tincture Spray
9 Global Medical Cannabis Market, By Compound 9.1 Introduction 9.2 Balanced THC & CBD 9.3 Cannabidiol (CBD)-Dominant 9.4 Tetrahydrocannabinol (THC)-Dominant
10 Global Medical Cannabis Market, By End-Users 10.1 Introduction 10.2 Pharmaceuticals Industry 10.3 Research and Development Centers 10.4 Others
11 Americas' Medical Cannabis Market 11.1 Introduction 11.2 Argentina 11.3 Brazil 11.4 Canada 11.5 Chile 11.6 Colombia 11.7 Mexico 11.8 Peru 11.9 United States 11.10 Rest of Americas
12 Europe's Medical Cannabis Market 12.1 Introduction 12.2 Austria 12.3 Belgium 12.4 Denmark 12.5 Finland 12.6 France 12.7 Germany 12.8 Italy 12.9 Netherlands 12.10 Norway 12.11 Poland 12.12 Russia 12.13 Spain 12.14 Sweden 12.15 Switzerland 12.16 United Kingdom 12.17 Rest of Europe
13 Middle East and Africa's Medical Cannabis Market 13.1 Introduction 13.2 Egypt 13.3 Israel 13.4 Qatar 13.5 Saudi Arabia 13.6 South Africa 13.7 United Arab Emirates 13.8 Rest of MEA
14 APAC's Medical Cannabis Market 14.1 Introduction 14.2 Australia 14.3 Bangladesh 14.4 China 14.5 India 14.6 Indonesia 14.7 Japan 14.8 Malaysia 14.9 Philippines 14.10 Singapore 14.11 South Korea 14.12 Sri Lanka 14.13 Thailand 14.14 Taiwan 14.15 Rest of Asia-Pacific
15 Competitive Landscape 15.1 Competitive Quadrant 15.2 Market Share Analysis 15.3 Strategic Initiatives 15.3.1 M&A and Investments 15.3.2 Partnerships and Collaborations 15.3.3 Product Developments and Improvements
16 Company Profiles 16.1 Aurora Cannabis Inc. 16.2 Cannabis Sativa, Inc. 16.3 CannaGrow Holdings, Inc. 16.4 Cannbit Ltd 16.5 Canopy Growth Corp 16.6 Cara Therapeutics Inc. 16.7 Cronos Group Inc. 16.8 Curaleaf Holdings Inc 16.9 Emerald Health Therapeutics, Inc. 16.10 Growblox Sciences, Inc. 16.11 Isodiol International Inc 16.12 Jazz Pharmaceuticals plc 16.13 Lexaria Corp. 16.14 Medical Marijuana, Inc. 16.15 OrganiGram Holding Inc. 16.16 The Hydropothecary Corp. 16.17 VIVO Cannabis Inc.
